Lexicon Pharmaceuticals to cut workforce by 60% to focus on drug development
Nov 22 (Reuters) - Lexicon Pharmaceuticals LXRX.O said on Friday it would reduce its workforce by about 60%, effective Dec. 31, to eliminate commercial activities and focus on drug development. (Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview